Related Experiment Videos
Reoperative MIDCAB grafting: 3-year clinical experience
J R Doty1, J D Salazar, J D Fonger
1Division of Cardiac Surgery, Johns Hopkins and Sinai Hospital of Baltimore, MD 21287, USA.
Summary
Minimally invasive direct coronary artery bypass (MIDCAB) offers reoperative patients a way to revascularize the heart without sternotomy or cardiopulmonary bypass. This technique shows promise for symptom relief and graft patency, though careful patient selection is key.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Cardiac Procedures
- Coronary Artery Bypass Grafting
Background:
- Minimally invasive direct coronary artery bypass (MIDCAB) is a surgical technique for reoperative patients.
- It avoids sternotomy and cardiopulmonary bypass, utilizing various incisions for revascularization.
- Graft conduits include internal mammary, gastroepiploic, radial arteries, and saphenous veins.
Purpose of the Study:
- To evaluate the efficacy and outcomes of reoperative MIDCAB grafting.
- To assess graft patency, patient symptom status, and complication rates.
- To compare reoperative MIDCAB with conventional coronary artery bypass grafting.
Main Methods:
- Performed MIDCAB grafting on 81 reoperative patients between January 1994 and August 1997.
- Utilized internal mammary, gastroepiploic, radial artery, or saphenous vein grafts.
- Graft follow-up included Doppler examination and selective recatheterization.
Main Results:
- 94% early graft patency rate, including interventions.
- 90% of patients remained symptom-free at a mean follow-up of 7.8 months.
- Lower rates of supraventricular arrhythmia and transfusion compared to conventional CABG.
Conclusions:
- Reoperative MIDCAB grafting effectively revascularizes focal areas of the heart.
- It avoids risks associated with resternotomy and cardiopulmonary bypass.
- Careful patient selection is crucial to minimize operative risk and optimize outcomes.